Research - Clinical Research - Stroke
Purpose of Stroke Research
- Speed the development of treatments and preventions
- Gain better understanding of the disease
- Improve quality of life for stroke patients
Current Study on Stroke Prevention:
Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) Trial; In collaboration with the University of California, San Francisco; supported by the National Institute of Neurological Disorders and Stroke (NINDS)
Acute stroke studies
The thrombolytic agent desmoteplase is a naturally occurring protease found in the in the saliva of the bat Desmodus rotundus. Desmoteplase dissolves occluding blood clots and restores blood flow to the affected brain area in a time-window extending up to 9 hours after symptom onset.
You may be eligible to participate if you have a diagnosis of stroke based on a physical examination conducted by a neurologist. Administration of the study medication is to begin within 9 hours of stroke symptoms
For more information on the UTMC stroke program contact:
Andrea Korsnack, RN, Certified Clinical Research Coordinator * 419-383-3801 * firstname.lastname@example.org.